In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 2, 2012, Pages 187-191

  Yang, Qiwen ^a   Xu, Yingchun ^a   Chen, Minjun ^a   Wang, Hui ^b   Sun, Hongli ^a   Hu, Yunjian ^c   Zhang, Rong ^d   Duan, Qiong ^e   Zhuo, Chao ^f   Cao, Bin ^g   Liu, Yong ^h   Yu, Yunsong ⁱ   Sun, Ziyong ^j   Chu, Yunzhuo ^h  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c BEIJING HOSPITAL   (China)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e People's Hospital of Jilin Province   (China)

^f Institute of Respiratory Disease   (China)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h CHINA MEDICAL UNIVERSITY   (China)

ⁱ ZHEJIANG UNIVERSITY   (China)

^j HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

more..

Author keywords

Antimicrobial resistance; Cefditoren; Haemophilus influenzae; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFDINIR; CEFDITOREN; CEFPODOXIME; CEFUROXIME; LEVOFLOXACIN; MOXIFLOXACIN; PENICILLIN G; PENICILLIN V;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BROTH DILUTION; CHINA; CITY; COMMUNITY ACQUIRED RESPIRATORY TRACT INFECTION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84861188148     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.005     Document Type: Article

References (16)

1. Anzueto A., Bishai W.R., Pottumarthy S. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis. Diagn Microbiol Infect Dis 2007, 57:S31-38.
2. Biedenbach D.J., Jones R.N. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations. Diagn Microbiol Infect Dis 2009, 64:202-212.
3. Biedenbach D.J., Jones R.N., Fritsche T.R. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States. Diagn Microbiol Infect Dis 2008, 61:240-244.
4. Clinical and Laboratory Standards Institute (CLSI) Methods for antimicrobial dilution and disk susceptibility testing if infrequently isolated or fastidious bacteria, approved guideline, M45-A 2006, CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute (CLSI) Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2009, CLSI, Wayne, PA. 8th ed., M7-A8.
6. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. Twentieth informational supplement, M100-S20 2010, CLSI, Wayne, PA.
7. Fritsche T.R., Biedenbach D.J., Jones R.N. Update of the activity of cefditoren and comparator oral beta-lactam agents tested against community-acquired Streptococcus pneumoniae isolates (USA, 2004-2006). J Chemother 2008, 20:170-174.
8. Huang H.H., Zhang Y.Y., Xiu Q.Y., Zhou X., Huang S.G., Lu Q., et al. Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis 2006, 25:369-374.
9. Kim I.S., Ki C.S., Kim S., Oh W.S., Peck K.R., Song J.H., et al. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob Agents Chemother 2007, 51:453-460.
10. Lee M.Y., Ko K.S., Oh W.S., Park S., Lee J.Y., Baek J.Y., et al. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries. Int J Antimicrob Agents 2006, 28:14-18.
11. Liu Y., Chen M., Zhao T., Wang H., Wang R., Cai B., et al. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population. BMC Infect Dis 2009, 18(9):31.
12. Nagai K., Davies T.A., Jacobs M.R., Appelbaum P.C. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2× on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob Agents Chemother 2002, 46:1273-1280.
13. Seral C., Suárez L., Rubio-Calvo C., Gómez-Lus R., Gimeno M., Coronel P., et al. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Diagn Microbiol Infect Dis 2008, 62:210-215.
14. Stefani S., Mezzatesta M.L., Fadda G., Mattina R., Palù G., Rossano F., et al. Antibacterial activity of cefditoren against major community-acquired respiratory pathogens recently isolated in Italy. J Chemother 2008, 20:561-569.
15. Tempera G., Furneri P.M., Carlone N.A., Cocuzza C., Rigoli R., Musumeci R., et al. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren. J Chemother 2010, 22:153-159.
16. Yamada M., Watanabe T., Miyara T., Baba N., Saito J., Takeuchi Y., et al. Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity. Antimicrob Agents Chemother 2007, 51:3902-3907.